DERM Delights With A Hat-trick, Shot In The Arm For APRI, FDA Nod For TEVA

Dermira Inc.'s (DERM) third and final phase III trial of Cimzia in adult patients with moderate-to-severe chronic plaque psoriasis has also met the key goals.

from RTT - Biotech http://ift.tt/2iV5Vai
via IFTTT